Back
ESC Premium Access

30 days and one year impact of the antithrombotic treatment following TAVI

Session: Poster session 5 - Valvular disease
Topic: Aortic valve disease
Speaker: Doctor P. Balagny (Paris, FR)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Pauline Balagny

Bichat APHP Site of Paris Nord University Hospital, Paris (France)
0 follower

26 more presentations in this session

Clinical profile and prognosis of acute heart failure complicating severe aortic stenosis: Insights from the CURRENT AS Registry

Speaker: Doctor K. Nagao (Kyoto, JP)

Access
Abstract
Like
Thumbnail

Effects of dabigatran on prothrombin, factor VII and tissue factor expression in human aortic valve interstitial cells

Speaker: Doctor E. Wypasek (Cracow, PL)

Access
Abstract
Slides
Like
Thumbnail

Clinical impact of permanent pacemaker after aortic valve implantation with corevalve prosthesis: long term follow-up.

Speaker: Doctor J. Lopez Aguilera (Cordoba, ES)

Access
Abstract
Slides
Like
Thumbnail

Prevalence and main correlates of right ventricular dysfunction in patients with severe aortic stenosis and preserved left ventricular ejection fraction

Speaker: Doctor A. Mateescu (Bucharest, RO)

Access
Abstract
Slides
Like
Thumbnail

Effect of body mass index on clinical outcomes and all-cause mortality in elderly patients undergoing transcatheter aortic valve replacement

Speaker: Sir M. Abawi (Utrecht, NL)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 5 - Valvular disease

Speakers: Doctor P. Balagny, Doctor K. Nagao, Doctor E. Wypasek, Doctor J. Lopez Aguilera, Doctor A. Mateescu...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources